Navigation Links
Arpida Provides Comprhensive Overview of Pivotal Phase III Trial Data
Date:4/17/2008

REINACH, Switzerland, April 17 /PRNewswire-FirstCall/ -- In order to give a comprehensive overview of the results of the two pivotal Phase III trials with intravenous iclaprim in complicated Skin and Skin Structure Infections (cSSSI), Arpida Ltd. (SWX: ARPN) today provides a table with the key data from the trials. Part of the data has already been published in previous press releases, while some additional statistical data are included that have not been announced before.

The efficacy data confirm the achievement of the pre-specified primary endpoint in the relevant populations in both trials. Moreover, pooling of the data from the two trials allows further powering and demonstrates that the pre-specified efficacy endpoint is achieved. Furthermore, the microbiological eradication rates for MRSA observed with iclaprim were very similar to those of the comparator. Finally, iclaprim showed a safety profile in the studies which was compatible with treatment of patients with cSSSI and compared favourably with the comparator.

Based on the Phase III results and on those of other studies carried out, Arpida is confident that intravenous iclaprim has compelling properties, both in terms of efficacy and safety. Arpida has filed a New Drug Application with the US FDA for intravenous iclaprim in cSSSI in March 2008.

The complete press release, including appendix, is available on http://www.arpida.com

Conference Call

Arpida will host a conference call to discuss this news release, 17 April

2008, at 8.30 am CET. The dial-in numbers are:

+41(0)91-610-56-00 (Europe)

+44(0)207-107-0611 (UK)

+1-866-291-4166 (USA)

The conference call (Call ID 15104, followed by the #) will be available

for play-back for 48 hours after the call by dialling:

+41(0)91-612-43-30 (Europe)

+44(0)207-108-6233 (UK)

+1-866-416-2558 (USA)

About Arpid
'/>"/>

SOURCE Arpida
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. USAID Provides Additional Wildfire Assistance to Greece
4. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
5. New knock-out gene model provides molecular clues to breast cancer
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. SIV infection of natural hosts provides new insights into HIV disease complexity
8. Microarray provides 3 genomic guides to breast cancer treatment decisions
9. Access Innovations Provides Support Services for Agis Network
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Physical Therapist Provides Injury Analysis for Fantasy Football
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... the premier women’s dress supplier, has recently released its ... of AngelWeddingDress.com to find more details. , Many ... a bridal party. AngelWeddingDress offers a variety of gorgeous ... wedding dresses are specially designed for 2015. , AngelWeddingDress ...
(Date:1/22/2015)... 22, 2015 Autocarinsurancebest.com has released a new ... commercial auto insurance policy . , Auto insurance quotes ... It is no longer necessary to call an agent or ... available online on a single website: http://autocarinsurancebest.com/ . , ...
(Date:1/22/2015)... 22, 2015 Yesterday, Senator Holly ... and Kristin Olsen (R-Modesto) were honored by the ... advancing biotechnology, biomedical science, medical device and pharmaceutical ... received the “2014 Life Sciences Champion” award from ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and ... relationship in an effort to further promote visibility and adoption ... has long made AMA journals available via its subscription services, ... JAMA Network. , Long known as both a ...
(Date:1/22/2015)... VA (PRWEB) January 22, 2015 Step ... power at the Science Museum of Virginia. Wicked Plants, ... , Wicked Plants unearths 75 poisonous, carnivorous and diabolical ... through each room to uncover the biochemical, physical and ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... Provides Patient Tips For Safe Plastic Surgery Procedures, ... Donda West,rapper Kanye West,s mother, raised questions about the ... death are still emerging,and include concerns over her physician,s ... in a lengthy surgery. "Patients should,be reassured that Donda ...
... & Bar, other partners and donors share in ... the new National,Pediatric Brain Tumor Consortium headquarters, ... in,translational research for exceptional patient care, MEMPHIS, ... and Chili,s Grill & Bar(R) celebrated the national,grand ...
... Following is a statement,by Linda A. Suydam, ... regarding today,s FDA public meeting seeking comments,on a ... of our member companies, CHPA was pleased to ... of expanded consumer,access to medicines. As the leading ...
... Date, WASHINGTON, Nov. 14 The following was,released by the National Kidney Foundation of ... Ball will feature entertainment by the ... of the ... community leaders. Guests will also enjoy cocktails, dinner, ...
... lessening of the drug may ease addiction, research suggests , ... of gradually decreasing levels of nicotine over a number of ... finds. , The study, conducted by researchers at the University ... Medical Center, included 20 adult smokers. They puffed on their ...
... OSS, Netherlands, Nov. 14 Asenapine -- a ... was shown to be,effective and well-tolerated in patients ... in the current issue of the Journal,of Clinical ... Psychiatric Association,s (APA) annual meeting and at the ...
Cached Medicine News:Health News:Guide to Minimizing Your Plastic Surgery Risks 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 3Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 4Health News:Statement From the Consumer Healthcare Products Association on Proposed New 'Third Class' of Medicines 2Health News:Nicotine-Reduced Cigarettes Could Boost Quitting 2Health News:Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia 2Health News:Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia 3Health News:Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia 4
(Date:1/23/2015)... 23, 2015   Leatt Corporation  (OTCQB: LEAT), a global ... all forms of sports, including extreme motor sports, and ... today that the UISP Lega Motociclismo Lombardia, an Italian ... to wear a neck brace during its racing competitions.  ...
(Date:1/23/2015)... 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... the development and sale of patented biopharmaceutical medicine, modernized ... ingredients (API) today announced the business and development progress ... 1. Following the September 2014 JCM application (No. ...
(Date:1/22/2015)... 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or ... Omega-3 therapies for cardiovascular disease and overall health is pleased ... in 2014 and its outlook for 2015 from the CEO, ... We would like to take this opportunity to ...
Breaking Medicine Technology:Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today ... will present a company update at the Morgan Stanley Global ... at 10:55 a.m. ET.   Interested parties may ... the investor section of the BioMarin website, www.BMRN.com . ...
... and NEW YORK, Sept. 7, 2011 ... a biopharmaceutical company leveraging its proprietary drug-delivery ... supportive care and diabetes, announced that it has contracted ... ESRX), to expand its specialty pharmacy and third party ...
Cached Medicine Technology:BioMarin to Present at the Morgan Stanley Global Healthcare Conference 2Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 2Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 3Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 4
The Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Lorgnette pinhole occluder...
Maddox rod and occluder...
Black multi-pinhole occluder...
Medicine Products: